Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial

被引：0
|
作者：
Lisa M. Pitchford
Patricia M. Driver
John C. Fuller
Wendell S. Akers
Naji N. Abumrad
Venkataraman Amarnath
Ginger L. Milne
Sheau-Chiann Chen
Fei Ye
L. Jackson Roberts
M. Benjamin Shoemaker
John A. Oates
John A. Rathmacher
Olivier Boutaud
机构：
[1] MTI BioTech,Department of Kinesiology
[2] Inc.,Department of Medicine, Division of Clinical Pharmacology
[3] Iowa State University,Department of Pharmaceutical Sciences
[4] Vanderbilt University Medical Center,Department of Pharmacology, Division of Clinical Pharmacology
[5] Lipscomb University College of Pharmacy,Department of Surgery
[6] Vanderbilt University,Department of Biostatistics
[7] Vanderbilt University Medical Center,Department of Medicine, Division of Cardiology
[8] Vanderbilt University Medical Center,Department of Animal Science
[9] Vanderbilt University Medical Center,undefined
[10] Iowa State University,undefined
来源：
BMC Pharmacology and Toxicology | / 21卷
关键词：
Safety; Pharmacokinetics; Humans; Salicylamine; γ-Ketoaldehydes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SPH3127: A Phase I, Randomized, Double-Blind, Placebo-Controlled Trial
    Jing, Shan
    Xu, Ranchi
    Yang, Kexu
    Liu, Wenfang
    Zhang, Leduo
    Ke, Ying
    Xia, Guangxin
    Lin, Yang
    CLINICAL THERAPEUTICS, 2021, 43 (04) : 735 - +
  • [32] A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat
    Remenova, Tatiana
    Morand, Olivier
    Amato, Dominick
    Chadha-Boreham, Harbajan
    Tsurutani, Scott
    Marquardt, Thorsten
    ORPHANET JOURNAL OF RARE DISEASES, 2015, 10
  • [33] Tolerability, safety, and pharmacokinetics of GR1603 injection in healthy subjects: a randomized, double-blind, placebo-controlled single-dose escalation clinical trial
    Huang, Xin
    Hong, Xiang
    Yang, Shuang
    Ye, Ling
    Yang, Xiaoyan
    Cui, Chang
    Wu, Qian
    Wang, Wei
    Huang, Jie
    Yang, Guoping
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2025, 34 (1-2) : 89 - 95
  • [34] Safety, tolerability, and pharmacokinetics of oral (S)-oxiracetam in Chinese healthy volunteers: A randomized, double-blind, controlled phase I study
    Zhang, Ting
    Tao, Yi
    Pu, Junliang
    Zhu, Mingxue
    Wan, Lei
    Tang, Chengyong
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 192
  • [35] Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy SubjectsA Randomized, Double-Blind, Placebo-Controlled, Phase I Study
    Michael Derks
    Judith Anzures-Cabrera
    Lynn Turnbull
    Mary Phelan
    Clinical Drug Investigation, 2011, 31 : 325 - 335
  • [36] Safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of aficamten in healthy Chinese participants: a randomized, double-blind, placebo-controlled, phase 1 study
    Zhao, Xue
    Liu, Hongzhong
    Tian, Wei
    Fang, Ligang
    Yu, Mengyang
    Wu, Xiaofei
    Liu, Aijing
    Wan, Ruijie
    Li, Li
    Luo, Jinghui
    Li, Yuqiong
    Liu, Bo
    He, Yu
    Chen, Xiaowen
    Li, Yuan
    Xu, Donghong
    Wang, Hongyun
    Han, Xiaohong
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [37] Safety, Tolerability and Pharmacokinetics of Dalcetrapib Following Single and Multiple Ascending Doses in Healthy Subjects A Randomized, Double-Blind, Placebo-Controlled, Phase I Study
    Derks, Michael
    Anzures-Cabrera, Judith
    Turnbull, Lynn
    Phelan, Mary
    CLINICAL DRUG INVESTIGATION, 2011, 31 (05) : 325 - 335
  • [38] First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers
    Pitchford, Lisa M.
    Rathmacher, John A.
    Fuller, John C., Jr.
    Daniels, J. Scott
    Morrison, Ryan D.
    Akers, Wendall S.
    Abumrad, Naji N.
    Amarnath, Venkataraman
    Currey, Patricia M.
    Roberts, L. Jackson
    Oates, John A.
    Boutaud, Olivier
    BMC PHARMACOLOGY & TOXICOLOGY, 2019, 20 (1):
  • [39] SAFETY AND TOLERABILITY OF MICROBIAL INULINASE SUPPLEMENTATION IN HEALTHY ADULTS: A PHASE 1, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Garvey, Sean M.
    LeMoire, Ashley
    Wang, Jun
    Lin, Lois
    Sharif, Bisma
    Bier, Anthony
    Baisley, Joshua
    Tinker, Kelly M.
    Boyd, Robert C.
    GASTROENTEROLOGY, 2024, 166 (05) : S876 - S876
  • [40] Clinical safety and pharmacokinetics of a novel oral niclosamide formulation compared with marketed niclosamide chewing tablets in healthy volunteers: A three-part randomized, double-blind, placebo-controlled trial
    Walther, Niklas
    Schultz-Heienbrok, Robert
    Stass, Heino
    Corman, Victor M.
    Gassen, Nils C.
    Mueller, Marcel A.
    Drosten, Christian
    Witzenrath, Martin
    Lee, Hweeling
    Posch, Maximilian G.
    PLOS ONE, 2025, 20 (02):
12345